Role of epicardial adipose tissue in the development of atrial fibrillation in hypertensive patients

Obesity is a progressing epidemic, the prevalence of which has doubled over the past 30 years. The distribution of adipose tissue is an important factor in predicting the risk of cardiovascular events. The most significant inflammatory activity is characteristic of epicardial adipose tissue (EAT), the role of which in the development of atrial fibrillation (AF) remains a subject of discussion.

Aim. To study the effect of EAT size on the development of AF in hypertensive (HTN) patients.

Material and methods. The study included 95 patients with HTN aged 38-72 years (mean age, 61,5±1,8 years), including 45 patients with paroxysmal AF (group I) and 50 patients in the comparison group (group II). In order to assess the severity of visceral obesity, all patients underwent a general examination and echocardiography. To determine the EAT volume, cardiac multislice computed tomography was performed.

Results. Echocardiography revealed that the EAT thickness was significantly greater in hypertensive patients with paroxysmal AF than in the comparison group: 11,6±0,8 and 8,6±0,4 mm, respectively (p<0,001). According to cardiac multislice computed tomography, a significant increase in EAT volume was revealed in patients of group I (4,6±0,4 ml) compared with group II (3,5±0,25 ml) (p=0,019). In hypertensive patients with paroxysmal AF, a positive moderate relationship between the EAT volume and left atrial volume was revealed (r=0,7, p=0,022). Multivariate analysis showed that in hypertensive patients, EAT thickness >10 mm and volume >6 ml can serve as integral markers of the onset of paroxysmal AF.

Conclusion. Integral markers of AF in hypertensive patients are an increase in the EAT thickness >10 mm (odds ratio, 4,1; 95% confidence interval, 1,1-5,6) and volume >6 ml (odds ratio 3,7; 95%, confidence interval 1,0-4,2).

1. Podzolkov V.I., Tarzimanova A.I., Gataulin R.G., Oganesyan K.A., Lobova N.V. The role of obesity in the development of atrial fibrillation: current problem status. Cardiovascular Therapy and Prevention. 2019;18(4):109-114. (In Russ.) https://doi.org/10.15829/1728-8800-2019-4-109-114

2. Drapkina OM, Nikolaeva MV. Pathogenic Mechanisms of Atrial Fibrillation in Obesity. Rational Pharmacotherapy in Cardiology 2016;12(5):582-589. (In Russ). DOI: 10.20996/1819-6446-2016-12-5-582-589

3. Abed HS, Wittert GA. Obesity and atrial fibrillation. Obes Rev. 2013 Nov;14(11):929-38. doi: 10.1111/obr.12056.

4. Abed HS, Samuel CS, Lau DH et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm 2013;10(1):90-100 doi:10.1016/j.hrthm.2012.08.043

5. Goudis CA, Korantzopoulos P, Ntalas IV et al. Obesity and atrial fibrillation: A comprehensive review of the pathophysiological mechanisms and links. J Cardiol. 2015;66(5):361-9. doi: 10.1016/j.jjcc.2015.04.002.

6. Mazurek T, Kiliszek M, Kobylecka M et al. Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am J Cardiol. 2014;113(9):1505-8. doi:10.1016/j.amjcard.2014.02.005.

7. Sepehri Shamloo A, Dagres N, Dinov B et al. Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2019 Jan 26; 22:132-138. doi: 10.1016/j.ijcha.2019.01.003

8. Zhu YM, Xu HX, Lu Q et al. Correlation between multi-slice spiral CT determined epicardial adipose tissue volume and atrial fibrillation. Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Dec 24;47(12):969-973. doi: 10.3760/cma.j.issn.0253-3758.2019.12.005.

9. Guauque-Olarte S, Gaudreault N, Piché MÈ, et al. The Transkriptome of Human Epicardial, Mediastinal and Subcutaneous Adipose Tissues in Men with Coronary Artery Disease. PLoS One. 2011;6(5):e19908. doi: 10.1371/journal.pone.0019908.

10. Hatem S, Redheuil A, Gandjbakhch A. Cardiac adipose tissue and atrial fibrillation: the perils of adiposity. Cardiovasc Res. 2016;109(4):502-9. doi: 10.1093/cvr/cvw001.

11. Haemers P, Hamdi H, Guedj K et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017 Jan 1;38(1):53-61. doi: 10.1093/eurheartj/ehv625.

12. Venteclef N, Guglielmi V, Balse E et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015 Apr 1;36(13):795-805a. doi: 10.1093/eurheartj/eht099.

13. Kim YG, Han KD, Choi JI et al. Impact of the Duration and Degree of Hypertension and Body Weight on New-Onset Atrial Fibrillation. Hypertension. 2019 Nov;74(5): e45-e51. doi: 10.1161/HYPERTENSIONAHA.119.13672

14. Zhu W., Wan R., Liu F. Relation of body mass index with adverse outcomes among patients with Atrial fibrillation: a meta-analysis and systematic review. J. Am. Heart Assoc. 2016;5:1–13. doi:10.1161/JAHA.116.004006

15. Zhu W, Zhang H, Guo L et al. Relationship between epicardial adipose tissue volume and atrial fibrillation: A systematic review and meta-analysis. Herz. 2016 Aug;41(5):421-7. doi: 10.1007/s00059-015-4387-z

16. Wong CX, Sun MT, Odutayo A et al. Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2016;9(12):e004378. doi:10.1161/CIRCEP.116.004378.